Drawing for SPECTRE

USPTO serial 97758898

SPECTRE

Reviewed by CopyMark Law Group

Reg. 7309060Status 700Registered
Filing date
Status date
Registration date
Feb 20, 2024
Examiner
VERHOSEK, WILLIAM T
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SPECTRE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clifford D. Hyra

Clifford D. Hyra Fresh IP PLC11710 Plaza America Drive Suite 2000Reston, VA 20190United States

Goods and services

ClassDescriptionStatusFirst use
009Apparatus for the technical measuring, testing and checking of the concentration of flavorings in beveragesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 23, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 23, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 22, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 22, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 22, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 22, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 22, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 20, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 20, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 31, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 19, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Oct 19, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 19, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 19, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 16, 2023DOCKASSIGNED TO EXAMINER—
Feb 11, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 10, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 21, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance